Abstract:Gasdermin (GSDM)-mediated pyroptosis is functionally involved in multiple diseases, but Gasdermin-B (GSDMB) exhibit cell death-dependent and independent activities in several pathologies including cancer. When the GSDMB pore-forming N-terminal domain is released by Granzyme-A cleavage, it provokes cancer cell death, but uncleaved GSDMB promotes multiple pro-tumoral effects (invasion, metastasis, and drug resistance). To uncover the mechanisms of GSDMB pyroptosis, here we determined the GSDMB regions essential for cell death and described for the first time a differential role of the four translated GSDMB isoforms ( GSDMB1-4 , that differ in the alternative usage of exons 6-7) in this process. Accordingly, we here prove that exon 6 translation is essential for GSDMB mediated pyroptosis, and therefore, GSDMB isoforms lacking this exon ( GSDMB1-2 ) cannot provoke cancer cell death. Consistently, in breast carcinomas the expression of GSDMB2 , and not exon 6-containing variants ( GSDMB3-4 ), associates with unfavourable clinical-pathological parameters. Mechanistically, we show that GSDMB N-terminal constructs containing exon-6 provoke cell membrane lysis and a concomitant mitochondrial damage. Moreover, we have identified specific residues within exon 6 and other regions of the N-terminal domain that are important for GSDMB-triggered cell death as well as for mitochondrial impairment. Additionally, we demonstrated that GSDMB cleavage by specific proteases (Granzyme-A, Neutrophil Elastase and caspases) have different effects on pyroptosis regulation. Thus, immunocyte-derived Granzyme-A can cleave all GSDMB isoforms, but in only those containing exon 6, this processing results in pyroptosis induction. By contrast, the cleavage of GSDMB isoforms by Neutrophil Elastase or caspases produces short N-terminal fragments with no cytotoxic activity, thus suggesting that these proteases act as inhibitory mechanisms of pyroptosis. Summarizing, our results have important implications for understanding the complex roles of GSDMB isoforms in cancer or other pathologies and for the future design of GSDMB-targeted therapies.

Apoptotic caspase-7 activation inhibits non-canonical pyroptosis by GSDMB cleavage

GSDMB promotes non-canonical pyroptosis by enhancing caspase-4 activity.

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

Gasdermin D is an Executor of Pyroptosis and Required for Interleukin-1Β Secretion

Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling

Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death

Molecular mechanism of pyroptosis and inflammasome activation

Caspase-1 cleaves Bid to release mitochondrial SMAC and drive secondary necrosis in the absence of GSDMD

Gasdermin D in pyroptosis

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death

Sphingosine-1-phosphate Receptor 2 Signaling Promotes Caspase-11-dependent Macrophage Pyroptosis and Worsens Escherichia Coli Sepsis Outcome.

Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis

Caspase-3/GSDME Mediated Pyroptosis: A Potential Pathway for Sepsis

Porcine Gasdermin D is a Substrate of Caspase-1 and an Executioner of Pyroptosis

Mechanism of Gasdermin D Recognition by Inflammatory Caspases and Their Inhibition by a Gasdermin D-derived Peptide Inhibitor

GSDMB involvement in the pathogenesis of abdominal aortic aneurysm through regulation of macrophage non-canonical pyroptosis

Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells

Molecular Mechanism and Immunological Function of Pyroptosis

Crosstalk of HDAC4, PP1, and GSDMD in controlling pyroptosis

Transcription factor Sp1 transcriptionally enhances GSDME expression for pyroptosis